BridgeMD
New treatment option for Pre-diabetes
Official title Continuous Glucose Monitoring (CGM) in Prediabetes
ClinicalTrials.gov ID: NCT07371546
What this study is testing
- What it's testing
- Part 1 and 2 of study (For Patient Participants) The purpose of this study is to examine if the wearing of a medical device called a continuous glucose monitor (CGM) can guide adults with prediabetes modify their behaviors and manage their health, compared to traditional health coaching. Prediabetes means the study participants have a higher-than-normal blood sugar level which is not high enough to be considered type 2 diabetes yet but will put them at risk of developing it.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 69
You may be able to join if
- Patient Participants
- Singaporean Citizen or Permanent Resident
- Age 21 - 69 years old
- Clinical diagnosis of prediabetes defined as a fasting glucose of 6.1-6.9 mmol/L and/or 2-hour glucose level of 7.8-11.0 mmol/L after an oral glucose...
- Owns a mobile phone that can download the Singapore FreeStyle LibreLink App
You likely can't join if
- Pregnant or planned pregnancy within the next six months
- Physical limitation that prevents the patient from engaging in physical exercise
- Cognitively impaired based on diagnosis of dementia or mild cognitive impairment (MCI) in the electronic health records (EHR)
- Not adequately proficient in English
- Currently enrolled in another study or program that involves weight loss or dietary modifications, or novel therapeutic drug or device
- Planned surgery in the next six months
See the full eligibility criteria
- Patient Participants
- Singaporean Citizen or Permanent Resident
- Age 21 - 69 years old
- Clinical diagnosis of prediabetes defined as a fasting glucose of 6.1-6.9 mmol/L and/or 2-hour glucose level of 7.8-11.0 mmol/L after an oral glucose tolerance test (Appropriate Care Guide, 2021) a. Can be...
- Owns a mobile phone that can download the Singapore FreeStyle LibreLink App
- Expressed willingness to use participate in the study, use the devices according to the study protocol during the study period, and to sign informed consent.
- Pregnant or planned pregnancy within the next six months
- Physical limitation that prevents the patient from engaging in physical exercise
- Cognitively impaired based on diagnosis of dementia or mild cognitive impairment (MCI) in the electronic health records (EHR)
- Not adequately proficient in English
- Currently enrolled in another study or program that involves weight loss or dietary modifications, or novel therapeutic drug or device
- Planned surgery in the next six months
- Not able to use smartphone or the Singapore FreeStyle LibreLink App despite coaching
- Any end-stage disease with life prognosis of \< 2 years
- Patients who are not willing or are not able to commit to the entire study program Healthcare Providers (HCP) Participants HCPs from Pasir Ris Polyclinic who self-reported to have treated adults with prediabetes will be...
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 69 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.